BRIEF-Ziopharm says patient death unrelated to study drug
July 19, 2016 at 08:34 AM EDT
* Provides update regarding phase I study of gene therapy candidate AD-RTS-HIL-12 in brain cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.